These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23875585)

  • 1. [The investigation of angiotensin converting enzyme I/D and plasminogen activator inhibitor-1 4G/5G polymorphisms in venous thromboembolism patients].
    Kaya H; Karkucak M; Salifoğlu H; Torun D; Kozan S; Tunca Y
    Tuberk Toraks; 2013; 61(2):88-95. PubMed ID: 23875585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
    Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
    Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
    Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
    Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
    Sakhteh M; Poopak B; Amirizadeh N; Shamshiri A; Bagheri A; Faranoush M
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
    Kurzawińska G; Barlik M; Drews K; Różycka A; Seremak-Mrozikiewicz A; Ożarowski M; Klejewski A; Czerny B; Wolski H
    Ginekol Pol; 2016; 87(4):271-6. PubMed ID: 27321098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J; Jelicic M; Stojkovic O
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Association Between Polymorphisms within PAI-1 and ACE genes and Ischemic Stroke Outcome After rt-PA Therapy.
    Dušanović Pjević M; Beslac Bumbaširevic L; Vojvodic L; Grk M; Maksimović N; Damnjanović T; Novaković I; Kačar K; Pesic M; Perovic D; Savic M; Maksic V; Trickovic J; Jekic B
    J Pharm Pharm Sci; 2019; 22(1):142-149. PubMed ID: 31013014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
    Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.
    Kim JJ; Choi YM; Lee SK; Yang KM; Paik EC; Jeong HJ; Jun JK; Han AR; Hong MA
    Am J Reprod Immunol; 2014 Dec; 72(6):571-6. PubMed ID: 25078885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH; Smolkin ME; Lamb JM; Brown NJ; Vaughan DE
    Clin Genet; 2002 Jul; 62(1):53-9. PubMed ID: 12123488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.